Scrip Dividend - total issued shares

RNS Number : 4362X

ConvaTec Group PLC

29 April 2019

 

                                                ConvaTec Group Plc

Scrip Dividend - total issued shares

Reading, United Kingdom (29 April 2019)

On 12 February 2019, the Board of Directors of ConvaTec Group Plc ("ConvaTec" or "the Company") proposed a final dividend in respect of 2018, subject to shareholder approval at the Annual General Meeting on 9 May 2019 of 3.983 cents per share (the "final dividend"). This final dividend is to be paid on 16 May 2019 to shareholders on the share register as at 5 April 2019. The dividend is payable in cash in Sterling to holders of ordinary shares. On 14 February 2019, the Company announced that a Scrip Dividend Scheme will be made available for this final dividend allowing shareholders to elect to receive their dividend in the form of new ordinary shares. The calculation price for the Scrip Dividend Scheme was announced on 11 April 2019.

It is confirmed that 11,198,285 ordinary shares of 10 pence each will be allotted and issued on 16 May 2019 by the Company to those shareholders who elected to receive the scrip dividend alternative. The shares will rank pari passu with the existing issued ordinary shares of the Company. Application will be made to the Financial Conduct Authority for the shares to be admitted to the Official List and to the London Stock Exchange for the shares to be admitted to trading.

Dealings in the shares issued under the scrip dividend scheme is expected to commence on 16 May 2019.

TIMETABLE

Key dates in respect of the scrip dividend scheme for the final dividend are:

Ex-dividend Date	4 April 2019
Record Date	5 April 2019
Scrip calculation price determined	4-10 April 2019 (inclusive)
Scrip calculation price available and announced	11 April 2019
Mandate delivery deadline for Shares held in uncertificated form	3.00 p.m. on 23 April 2019
Mandate delivery deadline for Shares held in certificated form	5.00 p.m. on 23 April 2019
Announcement of the total amount of new shares to be issued	29 April 2019
Dividend payment date	16 May 2019
Dispatch of statement in accordance with section 7 of Scheme Rules and share certificates, CREST accounts credited/updated, and first day of dealings in New Shares	16 May 2019

Enquiries

Media

Bobby Leach, VP Group Corporate Affairs, ConvaTec                    [phone]

Alastair Elwen, Finsbury                                                                   [phone]

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec                             [phone]

Mark Reynolds, Director Investor Relations, ConvaTec                  [phone]

[e-mail]

LEI:   213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

# # #

 

END

 

 

DIVLLFEFSTIAFIA